>全球无虹膜治疗市场，按产品（仪器、透析设备、内窥镜、激光和碎石设备、内窥镜和成像设备、机器人系统、充气器、内窥镜液体管理系统、尿动力学系统、消耗品及配件、透析消耗品、导管、导丝、检索设备和提取器、手术解剖器、镊子和持针器、扩张器组和尿道通路鞘、支架、活检设备、管和远端附件、引流袋、其他消耗品及配件）、疾病（肾脏疾病、泌尿系统癌症和前列腺增生 (BPH)、盆腔器官脱垂、其他疾病）、技术（微创手术、机器人手术、其他）、应用（前列腺增生、前列腺癌、尿石、尿失禁、其他）、最终用户（医院和诊所、透析中心、门诊服务、其他）- 行业趋势和预测到 2031 年。
无虹膜症治疗市场分析和规模
据估计，在普通人群中，肾结石的发病率约为 10%-15%。BPH 的发病率随着年龄的增长而增加，据估计，51-60 岁的男性中约有 50% 患有 BPH，80 岁以上的男性中高达 90% 患有 BPH。前列腺癌的发病率在全球各地有所不同，北美、欧洲和澳大利亚的发病率较高。在美国，据估计大约有九分之一的男性在其一生中会被诊断出患有前列腺癌，UTI 的发病率因年龄、性别和其他风险因素而异。据估计，大约 40%-60% 的女性在其一生中会经历至少一次 UTI，18-24 岁有性生活的女性发病率最高。由于泌尿系统疾病的发病率较高，用于治疗和诊断无虹膜症的治疗将在预测期内实现丰厚的增长。
Data Bridge Market Research 分析，全球无虹膜治疗市场规模在 2023 年为 415.4789 亿美元，到 2031 年将飙升至 573.0002 亿美元，预计在预测期内的复合年增长率为 4.10%。这表明了市场价值。由于对更好的手术和诊断治疗方法的需求不断增长，“仪器”在全球无虹膜治疗市场的产品领域占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
无虹膜症治疗市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品（仪器、透析设备、内窥镜、激光和碎石设备、内窥镜和成像设备、机器人系统、气腹机、内窥镜液体管理系统、尿动力学系统、耗材及配件、透析耗材、导管、导丝、检索设备和提取器、手术解剖器、镊子和持针器、扩张器套件和尿道通路鞘、支架、活检设备、管和远端附件、引流袋、其他耗材及配件）、疾病（肾脏疾病、泌尿系统癌症和前列腺增生 (BPH)、盆腔器官脱垂、其他疾病）、技术（微创手术、机器人手术、其他）、应用（前列腺增生、前列腺癌、尿石、尿失禁、其他）、最终用户（医院和诊所、透析中心、门诊服务、其他） |
|
覆盖国家 |
美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区 |
|
涵盖的市场参与者 |
美敦力（爱尔兰）、西门子（德国）、雅培（美国）、通用电气（美国）、BD（美国）、史赛克（美国）、波士顿科学公司（美国）、康德乐（美国）、直觉外科（美国）、库克（美国）、奥林巴斯株式会社（日本）、强生服务公司（美国）、费森尤斯医疗股份公司（德国）、百特（美国）、理查德·沃尔夫有限公司（德国）、多尼尔医疗科技公司（德国）、卡尔史托斯股份公司（德国）、Endo Pharmaceuticals Inc.（美国）、HealthTronics Inc.（美国）、MEDI TECH DEVICES PVT LTD（印度）、Coloplast Corp（美国）等 |
|
市场机会 |
|
市场定义
无虹膜治疗是指用于诊断各种与泌尿系统相关的疾病和病症的医疗设备。这些设备有助于治疗前列腺肥大、膀胱癌、前列腺癌和肾结石等慢性肾病。无虹膜治疗可以提高治疗效率并缩短患者的康复时间。
全球无虹膜症治疗市场动态
驱动程序
- 泌尿系统疾病患病率不断上升
尿失禁、肾结石、尿路感染和前列腺癌等泌尿系统疾病的发病率不断上升，是全球无虹膜治疗市场的主要驱动因素之一。随着这些疾病的发病率不断上升，对无虹膜治疗的诊断和治疗需求也随之增加。
- 提高认识和患者教育
Growing awareness about urological disorders, their symptoms, and available treatment options has led to greater patient demand for effective and minimally invasive aniridia treatment. Patient education initiatives and campaigns by healthcare organizations and medical professionals have contributed to increased awareness and early detection of urological conditions.
Opportunity
- Rising Demand for Home-Based Healthcare
There is a growing trend towards home-based healthcare, driven by factors such as cost-effectiveness, convenience, and patient preference. Aniridia treatment that can be used at home for self-monitoring, diagnosis, and treatment of certain urological conditions, such as urinary incontinence or urinary catheterization, present opportunities for market expansion.
Restraint/Challenge
- High Cost of Aniridia Treatment
Aniridia treatment can be expensive, especially advanced technologies such as robotic surgical systems and laser-based devices. The high cost of these devices can limit their adoption, particularly in healthcare systems with budget constraints or in regions with lower healthcare spending.
Recent Developments
- In July 2021, Boston Scientific announced the launch of its LithoVue Empower Retrieval Deployment Device, a minimally invasive device designed to simplify the retrieval of kidney stones during ureteroscopic lithotripsy procedures
- In June 2021, Cook Medical received FDA clearance for its Zenith Alpha thoracic endovascular grafting system. This device is used for the minimally invasive repair of thoracic aortic aneurysms and dissections
- In May 2021, Olympus Corporation launched its Soltive Super Pulsed Laser System for urology procedures. This laser system offers enhanced precision and control for the treatment of kidney stones and benign prostatic hyperplasia
- In May 2021, Teleflex announced the FDA clearance of its UroLift Advanced Tissue Control (ATC) System for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. The UroLift ATC system provides improved tissue manipulation and control during the procedure
Global Aniridia Treatment Market Scope
The global aniridia treatment market is segmented on the basis of product, disease, technology, application and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Instruments
- Dialysis Devices
- Endoscopes
- Laser and Lithotripsy Devices
- Endovision and Imaging Devices
- Robotic Systems
- Insufflators
- Endoscopy Fluid Management Systems
- Urodynamic Systems
- Consumables and Accessories
- Dialysis Consumables
- Catheters
- Guidewires
- Retrieval Devices and Extractors
- Surgical Dissectors
- Forceps and Needle Holders
- Dilator Sets and Urethral Access Sheaths
- Stents
- Biopsy Devices
- Tubes and Distal Attachments
- Drainage Bags
- Other Consumables and Accessories
Disease
- Kidney Diseases
- Urological Cancer and BPH
- Pelvic Organ Prolapse
- Other Diseases
Technology
- Minimally Invasive Surgery
- Robotic Surgery
- Others
Application
- Benign Prostatic Hyperplasia
- Prostate Cancer
- Urinary Stones
- Urinary Incontinence
- Others
End-Users
- Hospitals and Clinics
- Dialysis Centers
- Ambulatory Services
- Others
Global Aniridia Treatment Market Regional Analysis/Insights
The global aniridia treatment market is analyzed and market size insights and trends are provided by country, product, disease, technology, application and end-users as referenced above.
The countries covered in the global aniridia treatment market are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
North America dominates the global aniridia treatment market because of the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people having urinary diseases.
Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for dental and oral care, the large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global aniridia treatment market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global aniridia treatment market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global aniridia treatment market.
Competitive Landscape and Global Aniridia Treatment Market Share Analysis
全球无虹膜治疗市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球无虹膜治疗市场的关注有关。
全球无虹膜症治疗市场的一些主要参与者包括：
- 美敦力（爱尔兰）
- 西门子（德国）
- 雅培（美国）
- 通用电气（美国）
- BD（美国）
- 史赛克（美国）
- 波士顿科学公司 (美国)
- 康德乐 (美国)
- 直觉外科（美国）
- 库克（美国）
- 奥林巴斯株式会社（日本）
- 强生服务公司 (美国)
- 费森尤斯医疗保健股份公司（德国）
- 百特（美国）
- Richard Wolf GmbH（德国）
- Dornier MedTech.（德国）
- KARL STORZ SE & Co. KG（德国）
- Endo Pharmaceuticals Inc.（美国）
- HealthTronics Inc.（美国）
- MEDI TECH DEVICES PVT LTD（印度）
- Coloplast Corp（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
